Press

Latest Press Articles

    Nov 01, 2023

    Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth

    Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.

    Sep 26, 2023

    Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles

    Sangine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…

    Sep 13, 2023

    Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Trans...

    Jan 09, 2023

    Sanguine Biosciences Partners with Broadoak Capital Partners to Accelerate Launch of Ne...

    Aug 11, 2022

    Fortune Best Small Workplaces – #30 out of 100 in the US

    Apr 16, 2021

    PODCAST: The Bio Report: Bringing the Trial to the Patient

    Apr 04, 2021

    Recovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research

    Aug 03, 2020

    Sanguine Bio Accelerates Pace in Vaccine Race
email

Subscribe to our Newsletter

Select what you would like to receive directly in your email